Skip to content

Welcome guest

Please login or register

RestoreX™ for Lapeyronie

The RestoreX™ is the subject of a patent validating the exclusivity of the dual traction force technology. It is manufactured in the USA by PathRight Medical, based in Orem, Utah.

Le docteur Landon Trost, urologue américain

Dr. Landon TROST

The RestoreX™ was invented by Dr. Landon TROST, an American Urologist specializing in Lapeyronie's disease and author of multiple studies and clinical recommendations concerning this pathology. He has no professional or financial ties with PathRight Medical, and his clinical publications concerning Lapeyronie's disease or the RestoreX™ have all been carried out in accordance with the ethical and scientific procedures defined by the AUA (American Urology Association).

Unique, efficient double traction force

The axial traction force is between 2.5 and 3 Kg and that on the counter-curvature between 4.5 and 5 Kg. The power of these 2 tractions is the main reason for the RestoreX™'s effectiveness and has no equivalent among other traction-therapy devices. To ensure that the penis does not escape when traction is applied, the glans is clamped onto a very wide base allowing it to be firmly secured and, to avoid pain, the pressure to be distributed over a large contact area.

The RestoreX™ is effective for correcting penile curvature but also for treating hourglass yards.

The RestoreX™ is, apart from surgery, the only treatment to have shown tangible results concerning recovery of penile length 1b, 2b.

The RestoreX™ benefits from CE marking, which classifies it as a genuine Medical Device.

M.J. Ziegelmann & al - 2019: Outcomes of a Novel Penile Traction Device in Men with Peyronie's Disease: A Randomized, Single-Blind, Controlled Trial

Prospective randomized reference study with RestoreX™ alone for treatment

110 patients, mean age 58 years, Lapeyronie anteriority: 49 months, mean curvature 59.3 degrees.

4 groups: 1 control group (number = 27) and 3 other RestoreX ™ groups with daily sessions of use: group 1 (number =28) → 30 min session, group 2 (number =28) → 60 min session, group 3 (number =27) → 90 min session. RestoreX use time divided equally (50/50) into axial traction and counter-curvature.

A. Results at 3 months, average use 47mn/day

  • Curvature reduction of 17.2°or 28% for 77% of patients who responded to treatment (control group
    = +1.3°).
  • Recovery of penis length : +1.6cm or +11% for 94% of patients who responded to treatment
    (control group = +0.3cm).
  • Improved erectile function according to IIEF score of 4.3 (control group = 0.7).
  • 47% of patients were unable to have sexual intercourse : at the end of 12 weeks, 80% of these reported having penetrative sex.
  • No adverse effects were noted.
  • 100% of patients who had previously tried another traction-therapy device said they preferred the RestoreX™.

B. 2 additional phases of clinical study at 6 (n=64) and 9 (n=63) months follow-up, daily use
average 31 min/day

  • 63% of patients reported improvements in curvature and length (+0.5cm).
  • The International Index of Erectile Function (IIEF) questionnaire score was also increased.
  • 84% of patients continued to use RestoreX™ after 9 months.

Commentaires sur cette étude clinique

La courbure moyenne observée lors de cette étude était de 59,3°, ce qui classifie quasiment cette valeur comme étant sévère (> 60°). La courbure moyenne, rapportée par les études cliniques, se situe généralement entre 30° et 50°.


L’antériorité moyenne de la maladie de Lapeyronie est de 49 mois ce qui implique une dureté exponentielle dans le temps de la plaque de fibrose ainsi qu’une rétraction croissante de l’albuginée.

Ces 2 critères, très exigeants, représentent un véritable défi pour le RestoreX™.

23% des patients n’ont pas constaté d’améliorations. Nous avons essayé de comprendre pourquoi ces patients ne réagissaient pas et les explications sont diverses : certains n'utilisaient pas l'appareil correctement, d'autres ne l'utilisaient pas du tout, et d'autres encore faisaient probablement tout ce qu'il fallait mais n'obtenaient pas de réponse. Nous ne savons pas pourquoi ce dernier groupe n'a pas répondu.

La réduction de la courbure à 3 mois est de 17,2°, soit 28% d’amélioration ce qui représente une évolution considérable. Les degrés sont une façon absolue de mesurer l'angulation, tandis que le pourcentage est une valeur relative qui varie selon l’importance de la courbure.

Par exemple, si une personne présente une courbure de 100° qui sera réduite de 40° avec le RestoreX™, elle constatera une amélioration de 60° et également de 60%. Mais, si une autre personne dont la courbure est de 40° enregistre, comme dans l’étude clinique, une amélioration de 20°, elle reconnaîtra une amélioration de 50% par rapport à la courbure d’origine.

You can't find the answer to your question and would like to know more

Your Cart

Your cart is currently empty

You might like...